Associated Papers
Insights on SNPs of Human Activation-Induced Cytidine Deaminase AID.
Koveshnikova EA et al.
International Journal of Molecular Sciences, 2025
The Finnish genetic heritage in 2022 - from diagnosis to translational research.
Uusimaa J et al.
Disease Models & Mechanisms, 2022
Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
Stranneheim H et al.
Genome Medicine, 2021
33726816 (PubMed )
Supplement: 13073_2021_855_MOESM3_ESM.xlsx › Reported_genes_and_variants
Clinical implications of experimental analyses of AID function on predictive computational tools: Challenge of missense variants.
Abolhassani H et al.
Clinical Genetics, 2020
Unexpectedly High Prevalence of Common Variable Immunodeficiency in Finland.
Selenius JS et al.
Frontiers in Immunology, 2017
Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland.
Trotta L et al.
European Journal of Human Genetics : Ejhg, 2016
Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.
Durandy A et al.
Autoimmunity, 2013
Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA et al.
Expert Review of Clinical Immunology, 2012
Inherited defects of immunoglobulin class switch recombination.
Kracker S et al.
Advances in Experimental Medicine and Biology, 2010
Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
Durandy A et al.
Human Mutation, 2006
Select a paper to view details